Amgen launched a direct-to-patient program Oct. 6 to offer its cholesterol medication Repatha at a reduced price. The AmgenNow program will provide Repatha for $239 per month — nearly 60% below the ...
Patient support programs continue to play a role in how pharmaceutical manufacturers address access and adherence challenges, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results